What happened
BioNote filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$21.9M (+14.49% year on year), operating profit of US$4.26M (+35.16% year on year) and net income of US$27.7M (+925.36% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$21.9M |
|---|---|
| Revenue vs a year earlier | +14.49% |
| Operating profit | US$4.26M |
| Net income | US$27.7M |
| Period | Q1 2026 (consolidated) |
| Filed | 2026-05-13, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260513800204 → open original filing |
Source: DART. Information only, not investment advice.